Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 28, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pyxis Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 26
| |||||||
Repare Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Pyxis Oncology, Inc.
| 139.35K |
—
|
—
| +208.52% | 206.19K |
Mar 24
| |||||||
Repare Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
May 13
| |||||||
Pyxis Oncology, Inc.
| 66.83K |
—
|
—
|
∞
| 66.83K |
Mar 31
| |||||||
Pyxis Oncology, Inc.
| 15.7K |
$12.74 | $200,018.00 |
∞
| 15.7K |
Nov 18
| |||||||
Repare Therapeutics Inc.
| 7.5K |
$28.08 | $210,600.00 |
∞
| 7.5K |
Nov 16
| |||||||
Pyxis Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Oct 7
| |||||||
Pyxis Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Repare Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 7
| |||||||
Repare Therapeutics Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Five Prime Therapeutics, Inc.
| -68.97K |
$38.00 | -$2,620,898.00 | -100.00% |
0
|
Apr 16
| |||||||
Five Prime Therapeutics, Inc.
| -11.09K |
$37.94 | -$420,678.72 | -13.85% | 68.97K |
Apr 9
| |||||||
Five Prime Therapeutics, Inc.
| 75K |
—
|
—
|
∞
| 75K |
Apr 13
| |||||||
Five Prime Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Foundation Medicine, Inc.
| -33.42K |
$137.00 | -$4,578,677.00 | -100.00% |
0
|
Jul 31
| |||||||
Foundation Medicine, Inc.
| 33.42K |
$68.20 | $2,279,312.20 |
∞
| 33.42K |
Jan 1
| |||||||
Foundation Medicine, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||